This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Cross, M H Search for Related Content PubMed PubMed Citation Articles by Cross, M H Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Heart Surgery Social Bookmarking                         What's this?

Autotransfusion in cardiac surgery

Department of Anaesthesia, The General Infirmary at Leeds, Great George Street, Leeds

There are a number of problems with allogeneic blood transfusion. Some of these problems are defined and can be quantified, such as the problem of rising cost or the risk of viral infection, but some of the problems are not well defined and it is only outcome data that point to allogeneic blood transfusion contributing to patient mortality and morbidity. Autotransfusion includes any technique in which the patient’s own blood is collected, processed and stored, followed by reinfusion when circumstances dictate. In the perioperative period of cardiac surgery, a number of techniques are recognized as useful in this context. Preoperative autologous donation, with or without erythropoietin supplementation, intraoperative acute normovolaemic haemodilution, intraoperative cell salvage, postoperative cell salvage (reinfusion of shed mediastinal blood) and platelet rich plasmapheresis are all techniques which are used with more or less enthusiasm to reduce the need for an allogeneic blood transfusion. Modification of the priming technique of the cardiopulmonary bypass circuit using an autologous blood prime is included in this review even though it does not fall strictly within the definition of autotransfusion.

Although autotransfusion is not the answer to every problem, there is no doubt that it should play a significant part in the strategy of blood conservation.

Perfusion, Vol. 16, No. 5, 391-400 (2001)
DOI: 10.1177/026765910101600509


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				G. J. Spalding, M. Hartrumpf, T. Sierig, N. Oesberg, C. G. Kirschke, and J. M. Albes Cost reduction of perioperative coagulation management in cardiac surgery: value of 'bedside' thrombelastography (ROTEM) Eur. J. Cardiothorac. Surg., June 1, 2007; 31(6): 1052 - 1057. [Abstract] [Full Text] [PDF]

				M J ten Brinke, P W Weerwind, S Teerenstra, J C. Feron, W van der Meer, and M H. Brouwer Leukocyte removal efficiency of cell-washed and unwashed whole blood: an in vitro study Perfusion, December 1, 2005; 20(6): 335 - 341. [Abstract] [PDF]

				S. Price, J. R. Pepper, and S. I. Jaggar Recombinant Human Erythropoietin Use in a Critically Ill Jehovah's Witness After Cardiac Surgery Anesth. Analg., August 1, 2005; 101(2): 325 - 327. [Abstract] [Full Text] [PDF]

				E. Sirvinskas, T. Lenkutis, L. Raliene, A. Veikutiene, J. Vaskelyte, and I. Marchertiene Influence of residual blood autotransfused from cardiopulmonary bypass circuit on clinical outcome after cardiac surgery Perfusion, March 1, 2005; 20(2): 71 - 75. [Abstract] [PDF]

				H. I. Flom-Halvorsen, E. Ovrum, R. Oystese, and F. Brosstad Quality of intraoperative autologous blood withdrawal used for retransfusion after cardiopulmonary bypass Ann. Thorac. Surg., September 1, 2003; 76(3): 744 - 748. [Abstract] [Full Text] [PDF]